In January 2026 a maxillofacial professor at Goethe University Frankfurt published a paper with the two men most associated with the claim that hidden holes in the jawbone make people ill. It reported that something does remain in the socket after a tooth comes out. It then declined to call that something a disease. Neither…
“I got attacked every single time from the podium,” says Dr Dominik Nischwitz, recalling how conventional dentists responded to his early conference lectures. “If they’d had tomatoes, they probably would have thrown them at me. Or spat at me.”
That was the price Nischwitz, author of It’s All in Your Mouth, founder of DNA Health…
“I never thought we would actually get a winner,” says Dr Jamie Justice, Executive Vice President of Health at XPRIZE.
She is talking about XPRIZE Healthspan, the project she oversees. It is a seven-year, $101 million global competition to develop therapies that restore the function people lose as they age.
To win, a team has…
The world’s most private longevity investment conference takes place in Switzerland next month and you are not on the list.
Don’t take it personally. Hardly anyone is.
Between the 14th and the 17th September approximately 140 people will gather in Gstaad for the annual Longevity Investors Conference. One third of them are speakers. The rest…
Updated 10 August 2026. Regulatory status current as of this date.
Most approved peptide medicines are legal when prescribed appropriately. But wellness and lifestyle peptides such as BPC-157, TB-500 and MOTS-c remain unapproved and unproven; the FDA’s July 2026 advisory vote did not make them approved or immediately legal to compound. UK rules depend partly…
Mo Elzek does not think that, in the coming years, you will be able to pop a magic pill and decide what age you want to be. He does, however, think that a cocktail of targeted rejuvenation therapies could have a profound impact on your healthspan and lifespan.
That distinction, borne out of deep understanding…
If you work in health, Christopher Snowdon is supposed to be the enemy. He defends smokers, opposes minimum pricing on alcohol and argues against sugar taxes.
He thinks the wellness industry is "mostly a force for bad" and that nutritional epidemiology, the science underpinning nearly everything you have ever been told about food, is a…
Seven of the 100 people ranked in the Unfiltered Longevity 100 for 2026 publish regularly for a general audience, such as a podcast, a newsletter or both. They are Peter Diamandis, Mark Hyman, Bryan Johnson, Matt Kaeberlein, Andrew Huberman, David Sinclair and Phil Newman. Three of them are working scientists and four are not.
Four…
The most credible voices in longevity are mostly not the most visible ones. Of the 100 people ranked in the Unfiltered Longevity 100 for 2026, 38 are working scientists whose standing rests on peer-reviewed output, institutional position and replication record rather than on audience. They are listed in full below.
Credibility and reach are close…
Data as of mid-2026
The longevity industry is legitimate as a scientific field and simultaneously carries a consumer marketing layer that is not. As of 2026 it has FDA-cleared human trials, published clinical data and institutional capital from sovereign wealth funds and national research agencies. It also has no approved drug that targets ageing itself,…



